Overexpression of EGFR is found in 14–91% of breast cancer and this has been correlated with disease progression and poor prognosis (Klijn et al, 1992; Fox et al, 1994; Klijn et al, 1994; Salomon et al, 1995). Here, EGFR is linked to breast cancer.